source
- Parabilis CEO Mathai Mammen on biotech's record IPOParabilis Medicines cemented the largest biotech IPO in industry history on Wednesday with its $670 million debut on the Nasdaq. But the Cambridge, MA-based drug developer won't be celebrating at t…Endpoints · 1mo ago↗ source
- Novartis and Orionis strike second molecular glue deal for $40M upfrontNovartis is doubling down on its partnership with Orionis Biosciences in a deal worth $40 million upfront and up to $1.4 billion spread across milestones. The Boston and Belgian biotech will ...Endpoints · 1mo ago↗ source
- SonoThera raises $125M for non-viral gene therapy approachSonoThera has secured $125 million to take its ultrasound-based gene therapy technology into the clinic. The company is focused on two lead programs in Duchenne muscular dystrophy and autosomal dom…